We are live on
!
Find out more
PCM
Puissance Capital Management Portfolio holdings
AUM
$17.3M
1-Year Est. Return
149.36%
This Fund
S&P 500
This Quarter
Est. Return
+62.54%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$123M
Cap. Flow
% of AUM
85.23%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
+$54.8M |
| 2 |
CHRN
ChronoScale Holdings
CHRN
|
+$38.1M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$16.1M |
| 4 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
+$14.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.21% |
| 2 | Healthcare | 11.25% |
Similar funds
FM
IAM
FP
AF
TCS
JJ
PCM
NC
Puissance Capital Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Puissance Capital Management, which disclosed 4 positions worth $145M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is ViewRay, Inc.: 6,842,975 shares worth $63.4M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, followed by Healthcare.
- Puissance Capital Management's largest Q4 2017 buy was ViewRay, Inc.: 6,842,975 shares worth $63.4M.
- Puissance Capital Management's ten largest holdings make up 100% of its $145M portfolio in Q4 2017.
- Puissance Capital Management disclosed 4 positions in Q4 2017, its first 13F filing on record.
Based on Puissance Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.